Micromedic – a Unique Cluster of Cancer Diagnostic Solutions
Micromedic Technologies Ltd. specializes in the development and commercialization of innovative in vitrocancer diagnostic products and solutions. Our portfolio includes state-of-the-art technologies involving gene expression, biomarker and histochemical assays for early cancer detection and personalized medicine.
Micromedic offers proprietary diagnostic solutions for multiple cancer diagnostic applications, providing practical answers to real unmet needs.
Micromedic is a public company traded on the Tel Aviv Stock Exchange (TASE: MCTC).